- Home
- ADAG vs CPIX Comparison
ADAG vs CPIX Comparison
Compare ADAG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- CPIX
- Stock Information
- Founded
- ADAG 2011
- CPIX 1999
- Country
- ADAG China
- CPIX United States
- Employees
- ADAG N/A
- CPIX N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ADAG Health Care
- CPIX Health Care
- Exchange
- ADAG Nasdaq
- CPIX Nasdaq
- Market Cap
- ADAG 76.3M
- CPIX 68.7M
- IPO Year
- ADAG 2021
- CPIX 2009
- Fundamental
- Price
- ADAG $2.07
- CPIX $5.24
- Analyst Decision
- ADAG Strong Buy
- CPIX
- Analyst Count
- ADAG 1
- CPIX 0
- Target Price
- ADAG $8.00
- CPIX N/A
- AVG Volume (30 Days)
- ADAG 21.4K
- CPIX 38.4K
- Earning Date
- ADAG 07-24-2025
- CPIX 05-06-2025
- Dividend Yield
- ADAG N/A
- CPIX N/A
- EPS Growth
- ADAG N/A
- CPIX N/A
- EPS
- ADAG N/A
- CPIX N/A
- Revenue
- ADAG $103,204.00
- CPIX $41,083,299.00
- Revenue This Year
- ADAG $6,488.89
- CPIX N/A
- Revenue Next Year
- ADAG $57.50
- CPIX N/A
- P/E Ratio
- ADAG N/A
- CPIX N/A
- Revenue Growth
- ADAG N/A
- CPIX 5.82
- 52 Week Low
- ADAG $1.33
- CPIX $1.04
- 52 Week High
- ADAG $3.58
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- ADAG 57.43
- CPIX 53.74
- Support Level
- ADAG $1.80
- CPIX $4.81
- Resistance Level
- ADAG $2.02
- CPIX $6.21
- Average True Range (ATR)
- ADAG 0.12
- CPIX 0.50
- MACD
- ADAG 0.02
- CPIX -0.00
- Stochastic Oscillator
- ADAG 67.31
- CPIX 38.00
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.